FORA Capital LLC Has $1.49 Million Stock Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

FORA Capital LLC reduced its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 79.4% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 19,029 shares of the company's stock after selling 73,340 shares during the quarter. FORA Capital LLC's holdings in GE HealthCare Technologies were worth $1,488,000 as of its most recent filing with the SEC.

Other large investors also recently modified their holdings of the company. Principal Financial Group Inc. increased its stake in GE HealthCare Technologies by 1.9% during the 3rd quarter. Principal Financial Group Inc. now owns 1,009,910 shares of the company's stock valued at $94,780,000 after buying an additional 19,010 shares during the period. JPMorgan Chase & Co. increased its stake in GE HealthCare Technologies by 29.8% during the 3rd quarter. JPMorgan Chase & Co. now owns 2,233,603 shares of the company's stock valued at $209,624,000 after buying an additional 512,778 shares during the period. Nordea Investment Management AB increased its stake in GE HealthCare Technologies by 30.2% during the 4th quarter. Nordea Investment Management AB now owns 43,632 shares of the company's stock valued at $3,429,000 after buying an additional 10,116 shares during the period. Park National Corp OH increased its stake in GE HealthCare Technologies by 6.0% during the 4th quarter. Park National Corp OH now owns 3,796 shares of the company's stock valued at $297,000 after buying an additional 216 shares during the period. Finally, First Hawaiian Bank increased its stake in GE HealthCare Technologies by 4.6% during the 4th quarter. First Hawaiian Bank now owns 30,011 shares of the company's stock valued at $2,346,000 after buying an additional 1,314 shares during the period. 82.06% of the stock is currently owned by institutional investors.

GE HealthCare Technologies Trading Down 0.9%

GE HealthCare Technologies stock traded down $0.63 during trading hours on Friday, reaching $69.87. 5,722,041 shares of the company's stock traded hands, compared to its average volume of 3,362,191. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04. GE HealthCare Technologies Inc. has a fifty-two week low of $57.65 and a fifty-two week high of $94.80. The firm has a market capitalization of $31.99 billion, a price-to-earnings ratio of 16.14, a PEG ratio of 3.19 and a beta of 1.21. The firm's 50 day moving average is $72.49 and its 200-day moving average is $80.58.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its quarterly earnings results on Wednesday, April 30th. The company reported $1.01 earnings per share for the quarter, beating analysts' consensus estimates of $0.91 by $0.10. The business had revenue of $4.78 billion for the quarter, compared to the consensus estimate of $4.66 billion. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. GE HealthCare Technologies's revenue for the quarter was up 2.7% on a year-over-year basis. During the same period last year, the company posted $0.90 EPS. On average, analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies declared that its board has authorized a stock repurchase plan on Wednesday, April 30th that permits the company to repurchase $1.00 billion in shares. This repurchase authorization permits the company to repurchase up to 3.1% of its shares through open market purchases. Shares repurchase plans are usually a sign that the company's management believes its shares are undervalued.

GE HealthCare Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Friday, April 25th will be paid a dividend of $0.035 per share. The ex-dividend date is Friday, April 25th. This represents a $0.14 dividend on an annualized basis and a yield of 0.20%. GE HealthCare Technologies's payout ratio is 2.95%.

Analyst Ratings Changes

Several equities analysts have commented on GEHC shares. BTIG Research set a $95.00 target price on shares of GE HealthCare Technologies and gave the company a "buy" rating in a research note on Monday, April 14th. Evercore ISI lowered their price objective on shares of GE HealthCare Technologies from $96.00 to $85.00 and set an "outperform" rating on the stock in a research note on Thursday, May 1st. Citigroup lowered their price objective on shares of GE HealthCare Technologies from $105.00 to $86.00 and set a "buy" rating on the stock in a research note on Wednesday, April 30th. Morgan Stanley lowered their price objective on shares of GE HealthCare Technologies from $86.00 to $78.00 and set an "equal weight" rating on the stock in a research note on Tuesday, May 6th. Finally, Piper Sandler lowered their price objective on shares of GE HealthCare Technologies from $104.00 to $88.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 23rd. Three investment analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $88.27.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.